Some echoviruses (EV) that bind decay-accelerating factor (DAF) also bind c
ells of human and murine origins in a DAF-independent manner. Pretreatment
of cells with heparinase 1 or heparin blocks the binding of radiolabeled vi
rus to the cell surface, and heparin prevents infection of rhabdomyosarcoma
cells by certain EV, including several low-passage clinical isolates of EV
6 and some EV that do not bind DAF. These studies suggest that heparan sul
fate may be of in vivo relevance as an attachment molecule for EV.